Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Clinical trial NCT00080002 · TERMINATED
Trial details
- NCT number
- NCT00080002
- Sponsor
- Enzon Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.